BioAge Labs Statistics
Share Statistics
BioAge Labs has 35.85M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding | 35.85M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | 64.22% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 980 |
FTD / Avg. Volume | 0.41% |
Short Selling Information
The latest short interest is 1.74M, so 4.86% of the outstanding
shares have been sold short.
Short Interest | 1.74M |
Short % of Shares Out | 4.86% |
Short % of Float | 5.71% |
Short Ratio (days to cover) | 10.28 |
Valuation Ratios
The PE ratio is -0.87 and the forward
PE ratio is -1.78.
BioAge Labs's PEG ratio is
0.04.
PE Ratio | -0.87 |
Forward PE | -1.78 |
PS Ratio | 0 |
Forward PS | n/a |
PB Ratio | 0.19 |
P/FCF Ratio | -1.2 |
PEG Ratio | 0.04 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BioAge Labs.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.86,
with a Debt / Equity ratio of 0.03.
Current Ratio | 12.86 |
Quick Ratio | 12.86 |
Debt / Equity | 0.03 |
Debt / EBITDA | -0.11 |
Debt / FCF | -0.17 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-1,146,919.35 |
Employee Count | 62 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0.77, so BioAge Labs's
price volatility has been higher than the market average.
Beta | 0.77 |
52-Week Price Change | n/a |
50-Day Moving Average | 3.91 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 49.6 |
Average Volume (20 Days) | 236,593 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -78.19M |
Net Income | -71.11M |
EBITDA | -78.19M |
EBIT | -73.48M |
Earnings Per Share (EPS) | -6.63 |
Full Income Statement Balance Sheet
The company has 354.35M in cash and 8.7M in
debt, giving a net cash position of 345.64M.
Cash & Cash Equivalents | 354.35M |
Total Debt | 8.7M |
Net Cash | 345.64M |
Retained Earnings | -252.81M |
Total Assets | 343.84M |
Working Capital | 301.07M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -51.52M
and capital expenditures -366K, giving a free cash flow of -51.89M.
Operating Cash Flow | -51.52M |
Capital Expenditures | -366K |
Free Cash Flow | -51.89M |
FCF Per Share | -4.84 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |